Cargando…

MCM-2, Ki-67, and EGFR downregulated expression levels in advanced stage laryngeal squamous cell carcinoma

We present the conceptual study investigated the capacity of minichromosome maintenance-2 (MCM-2), Ki-67, and epidermal growth factor receptor (EGFR) to assess the severity and progression of laryngeal squamous cell carcinoma (LSCC) disease and to study the correlations among these markers. A total...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vivatvakin, Sarocha, Ratchataswan, Thanaporn, Leesutipornchai, Thiratest, Ruangritchankul, Komkrit, Keelawat, Somboon, Mahattanasakul, Patnarin, Bongsebandhu-phubhakdi, Saknan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285532/ https://www.ncbi.nlm.nih.gov/pubmed/34272446 http://dx.doi.org/10.1038/s41598-021-94077-9

Ejemplares similares

Evaluation of NID2 promoter methylation for screening of Oral squamous cell carcinoma
por: Srisuttee, Ratakorn, et al.
Publicado: (2020)

Monoamine Levels and Parkinson’s Disease Progression: Evidence From a High-Performance Liquid Chromatography Study
por: Wichit, Patsorn, et al.
Publicado: (2021)

Human papillomavirus in anal biopsy tissues and liquid-based cytology samples of HIV-positive and HIV-negative Thai men who have sex with men
por: Pankam, Tippawan, et al.
Publicado: (2017)

Immunoexpression of Ki-67, MCM2, and MCM3 in Ameloblastoma and Ameloblastic Carcinoma and Their Correlations with Clinical and Histopathological Patterns
por: Carreón-Burciaga, Ramón Gil, et al.
Publicado: (2015)

MCM6 versus Ki-67 in diagnosis of luminal molecular subtypes of breast cancers
por: Sadeghian, Dorsay, et al.
Publicado: (2022)

Vimentin expression status is a potential biomarker for brain metastasis development in EGFR-mutant NSCLC patients
por: Teocharoen, Rattanawadee, et al.
Publicado: (2021)

Prognostic significance of MCM2, Ki-67 and gelsolin in non-small cell lung cancer
por: Yang, Jun, et al.
Publicado: (2006)

Ki-67 and MCM-2 in Dental Follicle and Odontogenic Cysts: The Effects of Inflammation on Proliferative Markers
por: Güler, Nurhan, et al.
Publicado: (2012)

Evaluation of the Ki-67 and MCM3 Expression in Cytologic Smear of Oral Squamous Cell Carcinoma
por: Rezazadeh, Fahimeh, et al.
Publicado: (2017)

Irisin Association with Ki-67, MCM3 and MT-I/II in Squamous Cell Carcinomas of the Larynx
por: Pinkowska, Agnieszka, et al.
Publicado: (2021)

Levodopa-induced dyskinesia in early-onset Parkinson’s disease (EOPD) associates with glucocerebrosidase mutation: A next-generation sequencing study in EOPD patients in Thailand
por: Thanprasertsuk, Sekh, et al.
Publicado: (2023)

MCM - 2 and Ki - 67 as proliferation markers in renal cell carcinoma: A quantitative and semi - quantitative analysis
por: Mehdi, Muhammad Zain, et al.
Publicado: (2016)

The role of p53, PCNA and Ki–67 as outcome predictors in the treatment of laryngeal cancer
por: Sarafoleanu, D, et al.
Publicado: (2009)

Ki-67 is overexpressed in human laryngeal carcinoma and contributes to the proliferation of HEp2 cells
por: Bai, Yanxia, et al.
Publicado: (2016)

Cortical spreading depression impairs hippocampal long-term potentiation by the alteration of glutamate receptor responses
por: Bongsebandhu-Phubhakdi, S, et al.
Publicado: (2013)

EHMTI-0199. CGRP modulates trigeminal ganglionic neuronal excitability in minimally low pH condition
por: Jansri, U, et al.
Publicado: (2014)

Expression of Mcm2, geminin and Ki67 in normal oral mucosa, oral epithelial dysplasias and their corresponding squamous-cell carcinomas
por: Torres-Rendon, A, et al.
Publicado: (2009)

Aberrant expression of minichromosome maintenance protein-2 and Ki67 in laryngeal squamous epithelial lesions
por: Chatrath, P, et al.
Publicado: (2003)

Bile Cast Nephropathy Because of Acute Liver Injury Associated With Selective Androgen Receptor Modulators
por: Arayangkool, Chinnawat, et al.
Publicado: (2023)

Digital imaging in the immunohistochemical evaluation of the proliferation markers Ki67, MCM2 and Geminin, in early breast cancer, and their putative prognostic value
por: Joshi, Shalaka, et al.
Publicado: (2015)

Ki-67 gene expression
por: Uxa, Sigrid, et al.
Publicado: (2021)

MCM4 and MCM7, potential novel proliferation markers, significantly correlated with Ki-67, Bmi1, and cyclin E expression in esophageal adenocarcinoma, squamous cell carcinoma, and precancerous lesions(,)
por: Choy, Bonnie, et al.
Publicado: (2016)

To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

67. INCREASED RISK OF BREAST CANCER BRAIN METASTASIS WITH EGFR AND Ki-67 EXPRESSION: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Job, Arun, et al.
Publicado: (2020)

Postimplantation pocket hematoma increases risk of cardiac implantable electronic device infection: A meta‐analysis
por: Kewcharoen, Jakrin, et al.
Publicado: (2021)

EHMTI-0308. Cortical spreading depression increases NR2A/NR2B ratio by altering numbers of nr2a and nr2b subunit-containing nmda receptors in the hippocampus
por: Hansrivijit, P, et al.
Publicado: (2014)

Deciphering migraine pain mechanisms through electrophysiological insights of trigeminal ganglion neurons
por: Vongseenin, S., et al.
Publicado: (2023)

Corrigendum: To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

Nine patients with KCNQ2-related neonatal seizures and functional studies of two missense variants
por: Chokvithaya, Suphalak, et al.
Publicado: (2023)

The intrinsically disorderly story of Ki-67
por: Remnant, Lucy, et al.
Publicado: (2021)

Mcm2 predicts recurrence hazard in stage Ta/T1 bladder cancer more accurately than CK20, Ki67 and histological grade
por: Burger, M, et al.
Publicado: (2007)

EGFR, CD10 and proliferation marker Ki67 expression in ameloblastoma: possible role in local recurrence
por: Abdel-Aziz, Azza, et al.
Publicado: (2012)

Differential Expression of RAGE, EGFR and Ki-67 in Primary Tumors and Lymph Node Deposits of Breast Carcinoma
por: Aboushousha, Tarek, et al.
Publicado: (2018)

Prognostic value of CYFRA 21 − 1 and Ki67 in advanced NSCLC patients with wild-type EGFR
por: Li, Tao, et al.
Publicado: (2023)

Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies
por: Fasanella, S, et al.
Publicado: (2011)

Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group
por: Nielsen, Torsten O, et al.
Publicado: (2020)

Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma
por: Ladstein, Rita G, et al.
Publicado: (2010)

Genistein-attenuated Gastric Injury on Indomethacin-induced Gastropathy in Rats
por: Vivatvakin, Sarocha, et al.
Publicado: (2017)

Immunolocalization of Ki-67 in different periodontal conditions
por: Preethi, Penubolu Lakshmi, et al.
Publicado: (2014)

Phospho-Akt Immunoreactivity in Prostate Cancer: Relationship to Disease Severity and Outcome, Ki67 and Phosphorylated EGFR Expression
por: Hammarsten, Peter, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_bibc81vr0thebc231ohdu2hs96